Functionalized Nanoparticles in Cancer Therapeutics, 2nd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 20 February 2025 | Viewed by 7471
Special Issue Editors
Interests: nanoparticles; liposomes; solubility improvement; chemotherapeutic delivery
Special Issues, Collections and Topics in MDPI journals
Interests: drug resistance; chemotherapy failure; drug–drug interaction; anticancer drug discovery; novel mechanisms
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is a leading cause of death, accounting for millions of lives lost worldwide. Drug discovery and development efforts have provided highly potent chemotherapeutic drug molecules for the treatment of various cancers. However, many cancer mortalities are due to high systemic exposures from conventional chemotherapeutic drugs to various organs and inadequate delivery to the tumor sites. Targeted delivery of drugs, via functional nanomedicines to cancer tumors in a “magic bullet” approach, selectively kills the tumor cells without harming the benign cells. Current clinical practice for cancer treatment is based on many functional nanomedicines for tumor targeting with minimal exposure to “normal” cells, thus avoiding toxicity to the patient.
This Special Issue covers the following nanomedicines:
- Protein, polymer, and lipid-based nanomedicines with multi functionalities such as targeted moieties, triggered stimuli responses, immunoevasion (pegylation), prolonged release, and protection of the drug from degradation;
- Inorganic nanomedicines with unique electromagnetic properties for tumor site-specific delivery and diagnostic and imaging capabilities;
- Nanomedicines prepared with various functional biomaterials with unique transport properties for tumor targeting via enhanced permeability and retention (EPR) effect.
Prof. Dr. R. Jayachandra Babu
Dr. Amit K. Tiwari
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liposomes
- polymeric nanoparticles
- dendrimer-based nanoparticles
- micellar nanoparticles
- inorganic nanoparticles
- small interfering RNA-based nanoparticles
- protein-based nanoparticles
- functional nanomaterials
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.